Skip to main content

Table 2 Single nucleotide polymorphisms employed in first stage

From: Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration

Marker[48]

Chromosome

Base-pair[49]

(Build 36.3)

Base-pair[49]

(Build 37.1)

Gene

rs1061170

1

194,925,860

196,659,237

CFH (exon 9)

rs2274700

1

194,949,570

196,682,947

CFH (exon 10)

rs403846

1

194,963,360

196,696,737

CFH (intron 14)

rs12144939

1

194,965,568

196,698,945

CFH (intron 15)

rs1409153

1

195,146,628

196,880,005

CFHR4

rs1750311

1

195,220,848

196,954,225

CFHR5

rs10922153

1

195,245,238

196,978,615

CFHR5

rs698859

1

195,274,988

197,008,365

F13B

rs2990510

1

195,287,281

197,020,658

F13B

rs9332739

6

32,011,783

31,903,804

C2

rs641153

6

32,022,159

31,914,180

CFB

rs10490924

10

124,204,438

124,214,448

LOC387155/ARMS2

rs2230199

19

6,669,387

6,718,387

C3